Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of $310.07 million. The enterprise value is $241.17 million.
| Market Cap | 310.07M |
| Enterprise Value | 241.17M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 59.74 million shares outstanding. The number of shares has increased by 64.72% in one year.
| Shares Outstanding | 59.74M |
| Shares Change (YoY) | +64.72% |
| Shares Change (QoQ) | -12.55% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 84.71% |
| Float | 26.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 204.38 |
| Forward PS | 186.85 |
| PB Ratio | 3.56 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 154.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.35, with a Debt / Equity ratio of 0.30.
| Current Ratio | 5.35 |
| Quick Ratio | n/a |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -74.10% and return on invested capital (ROIC) is -57.71%.
| Return on Equity (ROE) | -74.10% |
| Return on Assets (ROA) | -51.90% |
| Return on Capital (ROIC) | -57.71% |
| Revenue Per Employee | $17,705 |
| Profits Per Employee | -$712,273 |
| Employee Count | 88 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +155.67% in the last 52 weeks. The beta is 0.23, so LYRA's price volatility has been lower than the market average.
| Beta (1Y) | 0.23 |
| 52-Week Price Change | +155.67% |
| 50-Day Moving Average | 5.50 |
| 200-Day Moving Average | 4.25 |
| Relative Strength Index (RSI) | 42.11 |
| Average Volume (30 Days) | 342,083 |
Short Selling Information
The latest short interest is 223,030, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 223,030 |
| Short Previous Month | 206,266 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 0.56 |
Income Statement
In the last 12 months, LYRA had revenue of $1.56 million and -$62.68 million in losses. Loss per share was -$1.26.
| Revenue | 1.56M |
| Gross Profit | 1.56M |
| Operating Income | -67.12M |
| Pretax Income | -62.62M |
| Net Income | -62.68M |
| EBITDA | -62.34M |
| EBIT | -62.62M |
| Loss Per Share | -$1.26 |
Balance Sheet
The company has $104.15 million in cash and $26.88 million in debt, giving a net cash position of $77.26 million or $1.29 per share.
| Cash & Cash Equivalents | 104.15M |
| Total Debt | 26.88M |
| Net Cash | 77.26M |
| Net Cash Per Share | $1.29 |
| Equity / Book Value | 89.42M |
| Book Value Per Share | 1.50 |
| Working Capital | 85.22M |
Cash Flow
In the last 12 months, operating cash flow was -$63.30 million and capital expenditures -$1.05 million, giving a free cash flow of -$64.35 million.
| Operating Cash Flow | -63.30M |
| Capital Expenditures | -1.05M |
| Free Cash Flow | -64.35M |
| FCF Per Share | -$1.29 |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,308.09% and -4,023.11%.
| Gross Margin | 100.00% |
| Operating Margin | -4,308.09% |
| Pretax Margin | -4,019.32% |
| Profit Margin | -4,023.11% |
| EBITDA Margin | -4,001.48% |
| EBIT Margin | -4,019.32% |
| FCF Margin | -4,130.36% |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -64.72% |
| Shareholder Yield | -64.72% |
| Earnings Yield | -19.68% |
| FCF Yield | -20.21% |
Analyst Forecast
The average price target for LYRA is $12.67, which is 144.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.67 |
| Price Target Difference | 144.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 172.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LYRA has an Altman Z-Score of -0.19. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.19 |
| Piotroski F-Score | n/a |